Department of Microbiology and Infectious Diseases, Nara Medical Universitygrid.410814.8, Kashihara, Nara, Japan.
BML, Inc., Kawagoe, Saitama, Japan.
Microbiol Spectr. 2022 Aug 31;10(4):e0120422. doi: 10.1128/spectrum.01204-22. Epub 2022 Jul 6.
Although the prevalence of carbapenem-resistant Enterobacterales remains low in Japan, these bacteria are a growing problem worldwide, owing to their multidrug resistance phenotype. We isolated a multidrug-resistant Providencia rettgeri strain, NR1418, harboring a rare variant, , a novel variant, designated , and . This strain is resistant to β-lactams, amikacin, levofloxacin, and colistin. Genomic analysis revealed that NR1418 carries two plasmids, designated pNR1418-1 and pNR1418-2. The pNR1418-1 plasmid harbors , , and , while the pNR1418-2 plasmid harbors , which is located in a class 1 integron. Both plasmids exhibit high similarities with the plasmid of the isolate BML2526, which also harbors and was identified in the same region of Japan as NR1418 at a different point in time. This indicates the possibility of the emergence and evolution of IMP-70-producing and suggests that the plasmid of BML2526 may have occurred following recombination of the two plasmids harbored by NR1418. Further, and were found on unique plasmids, indicating that they likely evolved through mutations and recombination. Although Providencia rettgeri is an opportunistic pathogen, its intrinsic resistance to colistin and tigecycline makes the treatment of carbapenem-resistant challenging. We isolated a multidrug-resistant strain which harbored a rare variant, , a novel variant, , and from a urinary sample obtained in Osaka, Japan. We investigated its genetic structure and evaluated the evolution of the plasmids carrying these genes. We show that , , and are present on unique plasmids and that they have high similarities to the plasmid of another IMP-70-producing isolate that was identified as being from the same location. The evolution of plasmids through mutations and recombination may play a role in the development and spread of multidrug resistance.
尽管碳青霉烯类耐药肠杆菌科(Carbapenem-resistant Enterobacterales,CRE)在日本的流行率仍然较低,但由于其多药耐药表型,这些细菌在全球范围内仍是一个日益严重的问题。我们分离到一株多药耐药普罗威登斯菌(Providencia rettgeri)NR1418 株,该菌携带一种罕见的 变体,一种新的 变体,命名为 和 。该菌株对β-内酰胺类、阿米卡星、左氧氟沙星和黏菌素耐药。基因组分析显示,NR1418 携带两个质粒,分别命名为 pNR1418-1 和 pNR1418-2。pNR1418-1 质粒携带 、 和 ,而 pNR1418-2 质粒携带 ,位于一个 I 类整合子中。两个质粒与 分离株 BML2526 的质粒高度相似,BML2526 质粒也携带 ,并在日本同一地区的不同时间点被分离到,与 NR1418 相同。这表明 IMP-70 产生的 和 的出现和进化是可能的,并表明 BML2526 质粒可能是通过 NR1418 携带的两个质粒重组产生的。此外, 和 位于独特的质粒上,表明它们可能是通过突变和重组进化而来。尽管普罗威登斯菌是一种机会性病原体,但它对黏菌素和替加环素的固有耐药性使得治疗碳青霉烯类耐药 变得具有挑战性。我们从日本大阪的尿液样本中分离到一株多药耐药 株,该菌携带一种罕见的 变体、一种新的 变体 、 和 。我们研究了其遗传结构,并评估了携带这些基因的质粒的进化。我们表明, 、 和 位于独特的质粒上,与另一个从同一地点分离的 IMP-70 产生 分离株的质粒高度相似。通过突变和重组进化的质粒可能在多药耐药性的发展和传播中发挥作用。